Differential expression of viral pathogen-associated molecular pattern receptors mRNA in Egyptian chronic hepatitis C virus patients

Background One possible mechanism utilized by hepatitis C virus (HCV) to escape from the host’s innate immune surveillance is modification of its pathogen-associated molecular patterns (PAMPs) by altering or hiding its RNA which interfering with toll-like receptors (TLRs) signaling and ultimately hi...

Full description

Saved in:
Bibliographic Details
Published inEgyptian Journal of Medical Human Genetics Vol. 22; no. 1; pp. 13 - 9
Main Authors Suef, Reda A., Mohamed, Ezz Elden M., Mansour, Mohamed T. M., Weigand, Kilian, Farag, Mohamed M. S.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 26.02.2021
Springer
Springer Nature B.V
SpringerOpen
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background One possible mechanism utilized by hepatitis C virus (HCV) to escape from the host’s innate immune surveillance is modification of its pathogen-associated molecular patterns (PAMPs) by altering or hiding its RNA which interfering with toll-like receptors (TLRs) signaling and ultimately hindering the production of proinflammatory cytokines, chemokines, and interferons (IFNs). This study aimed to examine the expression levels of TLR3, TLR7, and IFN-α to investigate the correlated expression pattern among them in chronic HCV patients. Patients included in this study were categorized into two different groups, non-treated chronic HCV patients and treated chronic HCV patients, in addition to healthy volunteers as a control group. The blood samples were assessed for HCVAb, HCVRNA, HCV genotypes, and different biochemical analyses. The mRNA levels of TLR3, TLR7, and IFN-α in peripheral blood of chronic HCV patients were quantitatively measured in comparison to healthy controls. Results The expression levels of TLR3, TLR7, and IFN-α were significantly downregulated in non-treated chronic HCV patients compared to both treated HCV patients and control subjects. On the other hand, treated HCV patients showed non-significant downregulation of the same three sensing receptors (TLR3, TLR7, and IFN-α) compared to control group. Obviously, the expression levels of IFN-α were positively correlated with the levels of both TLR3 and TLR7. Conclusion The exhausted innate immunity against HCV may correlate to HCV downregulation of TLR3 and TLR7 expression on innate immune cells with a subsequent decrease in INF-α production and the possibility of targeting these receptors to enhance the immune response and clear the infection needs further studies.
AbstractList Background One possible mechanism utilized by hepatitis C virus (HCV) to escape from the host's innate immune surveillance is modification of its pathogen-associated molecular patterns (PAMPs) by altering or hiding its RNA which interfering with toll-like receptors (TLRs) signaling and ultimately hindering the production of proinflammatory cytokines, chemokines, and interferons (IFNs). This study aimed to examine the expression levels of TLR3, TLR7, and IFN-[alpha] to investigate the correlated expression pattern among them in chronic HCV patients. Patients included in this study were categorized into two different groups, non-treated chronic HCV patients and treated chronic HCV patients, in addition to healthy volunteers as a control group. The blood samples were assessed for HCVAb, HCVRNA, HCV genotypes, and different biochemical analyses. The mRNA levels of TLR3, TLR7, and IFN-[alpha] in peripheral blood of chronic HCV patients were quantitatively measured in comparison to healthy controls. Results The expression levels of TLR3, TLR7, and IFN-[alpha] were significantly downregulated in non-treated chronic HCV patients compared to both treated HCV patients and control subjects. On the other hand, treated HCV patients showed non-significant downregulation of the same three sensing receptors (TLR3, TLR7, and IFN-[alpha]) compared to control group. Obviously, the expression levels of IFN-[alpha] were positively correlated with the levels of both TLR3 and TLR7. Conclusion The exhausted innate immunity against HCV may correlate to HCV downregulation of TLR3 and TLR7 expression on innate immune cells with a subsequent decrease in INF-[alpha] production and the possibility of targeting these receptors to enhance the immune response and clear the infection needs further studies.
BackgroundOne possible mechanism utilized by hepatitis C virus (HCV) to escape from the host’s innate immune surveillance is modification of its pathogen-associated molecular patterns (PAMPs) by altering or hiding its RNA which interfering with toll-like receptors (TLRs) signaling and ultimately hindering the production of proinflammatory cytokines, chemokines, and interferons (IFNs). This study aimed to examine the expression levels of TLR3, TLR7, and IFN-α to investigate the correlated expression pattern among them in chronic HCV patients. Patients included in this study were categorized into two different groups, non-treated chronic HCV patients and treated chronic HCV patients, in addition to healthy volunteers as a control group. The blood samples were assessed for HCVAb, HCVRNA, HCV genotypes, and different biochemical analyses. The mRNA levels of TLR3, TLR7, and IFN-α in peripheral blood of chronic HCV patients were quantitatively measured in comparison to healthy controls.ResultsThe expression levels of TLR3, TLR7, and IFN-α were significantly downregulated in non-treated chronic HCV patients compared to both treated HCV patients and control subjects. On the other hand, treated HCV patients showed non-significant downregulation of the same three sensing receptors (TLR3, TLR7, and IFN-α) compared to control group. Obviously, the expression levels of IFN-α were positively correlated with the levels of both TLR3 and TLR7.ConclusionThe exhausted innate immunity against HCV may correlate to HCV downregulation of TLR3 and TLR7 expression on innate immune cells with a subsequent decrease in INF-α production and the possibility of targeting these receptors to enhance the immune response and clear the infection needs further studies.
One possible mechanism utilized by hepatitis C virus (HCV) to escape from the host's innate immune surveillance is modification of its pathogen-associated molecular patterns (PAMPs) by altering or hiding its RNA which interfering with toll-like receptors (TLRs) signaling and ultimately hindering the production of proinflammatory cytokines, chemokines, and interferons (IFNs). This study aimed to examine the expression levels of TLR3, TLR7, and IFN-[alpha] to investigate the correlated expression pattern among them in chronic HCV patients. Patients included in this study were categorized into two different groups, non-treated chronic HCV patients and treated chronic HCV patients, in addition to healthy volunteers as a control group. The blood samples were assessed for HCVAb, HCVRNA, HCV genotypes, and different biochemical analyses. The mRNA levels of TLR3, TLR7, and IFN-[alpha] in peripheral blood of chronic HCV patients were quantitatively measured in comparison to healthy controls. The expression levels of TLR3, TLR7, and IFN-[alpha] were significantly downregulated in non-treated chronic HCV patients compared to both treated HCV patients and control subjects. On the other hand, treated HCV patients showed non-significant downregulation of the same three sensing receptors (TLR3, TLR7, and IFN-[alpha]) compared to control group. Obviously, the expression levels of IFN-[alpha] were positively correlated with the levels of both TLR3 and TLR7. The exhausted innate immunity against HCV may correlate to HCV downregulation of TLR3 and TLR7 expression on innate immune cells with a subsequent decrease in INF-[alpha] production and the possibility of targeting these receptors to enhance the immune response and clear the infection needs further studies.
Background One possible mechanism utilized by hepatitis C virus (HCV) to escape from the host’s innate immune surveillance is modification of its pathogen-associated molecular patterns (PAMPs) by altering or hiding its RNA which interfering with toll-like receptors (TLRs) signaling and ultimately hindering the production of proinflammatory cytokines, chemokines, and interferons (IFNs). This study aimed to examine the expression levels of TLR3, TLR7, and IFN-α to investigate the correlated expression pattern among them in chronic HCV patients. Patients included in this study were categorized into two different groups, non-treated chronic HCV patients and treated chronic HCV patients, in addition to healthy volunteers as a control group. The blood samples were assessed for HCVAb, HCVRNA, HCV genotypes, and different biochemical analyses. The mRNA levels of TLR3, TLR7, and IFN-α in peripheral blood of chronic HCV patients were quantitatively measured in comparison to healthy controls. Results The expression levels of TLR3, TLR7, and IFN-α were significantly downregulated in non-treated chronic HCV patients compared to both treated HCV patients and control subjects. On the other hand, treated HCV patients showed non-significant downregulation of the same three sensing receptors (TLR3, TLR7, and IFN-α) compared to control group. Obviously, the expression levels of IFN-α were positively correlated with the levels of both TLR3 and TLR7. Conclusion The exhausted innate immunity against HCV may correlate to HCV downregulation of TLR3 and TLR7 expression on innate immune cells with a subsequent decrease in INF-α production and the possibility of targeting these receptors to enhance the immune response and clear the infection needs further studies.
Abstract Background One possible mechanism utilized by hepatitis C virus (HCV) to escape from the host’s innate immune surveillance is modification of its pathogen-associated molecular patterns (PAMPs) by altering or hiding its RNA which interfering with toll-like receptors (TLRs) signaling and ultimately hindering the production of proinflammatory cytokines, chemokines, and interferons (IFNs). This study aimed to examine the expression levels of TLR3, TLR7, and IFN-α to investigate the correlated expression pattern among them in chronic HCV patients. Patients included in this study were categorized into two different groups, non-treated chronic HCV patients and treated chronic HCV patients, in addition to healthy volunteers as a control group. The blood samples were assessed for HCVAb, HCVRNA, HCV genotypes, and different biochemical analyses. The mRNA levels of TLR3, TLR7, and IFN-α in peripheral blood of chronic HCV patients were quantitatively measured in comparison to healthy controls. Results The expression levels of TLR3, TLR7, and IFN-α were significantly downregulated in non-treated chronic HCV patients compared to both treated HCV patients and control subjects. On the other hand, treated HCV patients showed non-significant downregulation of the same three sensing receptors (TLR3, TLR7, and IFN-α) compared to control group. Obviously, the expression levels of IFN-α were positively correlated with the levels of both TLR3 and TLR7. Conclusion The exhausted innate immunity against HCV may correlate to HCV downregulation of TLR3 and TLR7 expression on innate immune cells with a subsequent decrease in INF-α production and the possibility of targeting these receptors to enhance the immune response and clear the infection needs further studies.
Audience Professional
Academic
Author Weigand, Kilian
Farag, Mohamed M. S.
Mohamed, Ezz Elden M.
Suef, Reda A.
Mansour, Mohamed T. M.
Author_xml – sequence: 1
  givenname: Reda A.
  surname: Suef
  fullname: Suef, Reda A.
  organization: Botany and Microbiology Department, Faculty of Science, Al-Azhar University
– sequence: 2
  givenname: Ezz Elden M.
  surname: Mohamed
  fullname: Mohamed, Ezz Elden M.
  organization: Botany and Microbiology Department, Faculty of Science, Al-Azhar University
– sequence: 3
  givenname: Mohamed T. M.
  surname: Mansour
  fullname: Mansour, Mohamed T. M.
  organization: Virology and Immunology Department, National Cancer Institute, Cairo University and Children Cancer Hospital Egypt
– sequence: 4
  givenname: Kilian
  surname: Weigand
  fullname: Weigand, Kilian
  organization: Department of Gastroenterology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg
– sequence: 5
  givenname: Mohamed M. S.
  orcidid: 0000-0003-0581-8576
  surname: Farag
  fullname: Farag, Mohamed M. S.
  email: mohamed.farag@azhar.edu.eg
  organization: Botany and Microbiology Department, Faculty of Science, Al-Azhar University
BookMark eNptkl9rFDEUxYNUcFv9Aj4FfJ6a_zPzuKy1FoqC6HNIMndms8wkY5IV-94PbrYrFKHkIXBzzu_ecM8luggxAELvKbmmtFMfs-BEsIYw2hBCOW_EK7RhpCcNE4JeoA2llDSd4uQNusz5QIiSvBUb9PjJjyMkCMWbGcOfNUHOPgYcR_zbp1pbTdnHCUJjco7OmwIDXuIM7jibdHotkAJO4GAtMWW8fP-6xT7gm-lhrdCA3T7F4B3eQxX74jPendDHfDL72jm_Ra9HM2d49---Qj8_3_zYfWnuv93e7bb3jZOKlUZY1xPZcccpEXJo2cCoA0t7pcCxtlO2JW4YhOu7TlonLOGGW9sLaTtJ-4Ffobszd4jmoNfkF5MedDRePxVimrRJxbsZNBUUBmmFstII07aWUyOsGMHJvgOglfXhzFpT_HWEXPQhHlOo42umWiIZlW3_rJpMhfowxpKMW3x2eqvavu5AKV5V1y-o6hlg8a5uevS1_p-Bnw25fiJMkJ6bU6JPidDnROiaCP2UCC34X2xUq60
CitedBy_id crossref_primary_10_3390_ijms23105475
ContentType Journal Article
Copyright The Author(s) 2021
COPYRIGHT 2021 Springer
The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2021
– notice: COPYRIGHT 2021 Springer
– notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
CWDGH
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
DOA
DOI 10.1186/s43042-021-00133-4
DatabaseName Springer Nature OA Free Journals
ProQuest Central (Corporate)
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
Middle East & Africa Database
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Biological Science Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
DOAJ Directory of Open Access Journals
DatabaseTitle Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Middle East & Africa Database
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList
Publicly Available Content Database



Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2090-2441
EndPage 9
ExternalDocumentID oai_doaj_org_article_141ed5b46b5a4a77b31a4b4fec598ee1
A679537663
10_1186_s43042_021_00133_4
GeographicLocations Egypt
United States--US
GeographicLocations_xml – name: Egypt
– name: United States--US
GroupedDBID C6C
---
-OY
0R~
4.4
457
4JU
53G
5VS
7X7
8FI
8FJ
8R4
8R5
AAEDT
AAFWJ
AAIKJ
AAKKN
ABDBF
ABEEZ
ABMAC
ABUWG
ACACY
ACGFS
ACIHN
ACPRK
ACUHS
ACULB
ADBBV
ADEZE
AEAQA
AFGXO
AFKRA
AFPKN
AFWDF
AGHFR
AHMBA
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
C24
CCPQU
CWDGH
DIK
EBD
EBS
EOJEC
ESX
FDB
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
IAO
IGS
IHR
INH
ITC
IXB
KQ8
KWQ
M7P
O-L
O9-
OBODZ
OK1
PEKGL
PHGZM
PHGZT
PIMPY
PMFND
Q2X
SEL
SES
SOJ
TUS
UKHRP
XH2
~8M
3V.
7XB
8FE
8FH
8FK
AZQEC
DWQXO
GNUQQ
K9.
LK8
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
ID FETCH-LOGICAL-c562t-4bc90583c31045d72d21ceb1966ec2786b70cdd4c9885bc4b03a3bb945b8519d3
IEDL.DBID C6C
ISSN 1110-8630
IngestDate Wed Aug 27 01:26:06 EDT 2025
Fri Jul 25 18:59:10 EDT 2025
Tue Jun 17 21:36:40 EDT 2025
Tue Jun 10 20:34:17 EDT 2025
Fri Feb 21 02:49:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Hepatitis C virus
TLR3 and TLR7 signaling
IFN-α transcription
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c562t-4bc90583c31045d72d21ceb1966ec2786b70cdd4c9885bc4b03a3bb945b8519d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ORCID 0000-0003-0581-8576
OpenAccessLink https://doi.org/10.1186/s43042-021-00133-4
PQID 2670521579
PQPubID 54962
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_141ed5b46b5a4a77b31a4b4fec598ee1
proquest_journals_2670521579
gale_infotracmisc_A679537663
gale_infotracacademiconefile_A679537663
springer_journals_10_1186_s43042_021_00133_4
PublicationCentury 2000
PublicationDate 2021-02-26
PublicationDateYYYYMMDD 2021-02-26
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-26
  day: 26
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Cairo
PublicationTitle Egyptian Journal of Medical Human Genetics
PublicationTitleAbbrev Egypt J Med Hum Genet
PublicationYear 2021
Publisher Springer Berlin Heidelberg
Springer
Springer Nature B.V
SpringerOpen
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer
– name: Springer Nature B.V
– name: SpringerOpen
References SahaBSzaboGInnate immune cell networking in hepatitis C virus infectionJ Leukoc Biol201496.57577661:CAS:528:DC%2BC2cXitFWns7bJ10.1189/jlb.4MR0314-141R
JacobsBLLanglandJOWhen two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNAVirology.19962193393491:CAS:528:DyaK28XjtVSgt74%3D10.1006/viro.1996.02598638399
RosadiniCVKaganJCMicrobial strategies for antagonizing toll-like-receptor signal transductionCurr Opin Immunol20153261701:CAS:528:DC%2BC2MXmtFWrsw%3D%3D10.1016/j.coi.2014.12.011
Dehghan-ManshadiMHadinedoushanHAmirbaigyMKRelative expression of toll-like receptors 2 and 7 mRNA in peripheral blood of patients with hepatitis CHepat Mon20151511e3042710.5812/hepatmon.30427268347884719121
MatsumotoMKikkawaSKohaseMEstablishment of a monoclonal antibody against human toll-like receptor 3 that blocks double-stranded RNA-mediated signalingBiochem Biophys Res Commun20022935136413691:CAS:528:DC%2BD38Xks1Ghu7c%3D10.1016/S0006-291X(02)00380-712054664
LiangCaoDingHepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathwayPLoS Pathog2018145e10070751:CAS:528:DC%2BC1cXhvFCmtrjM10.1371/journal.ppat.1007075297825325983870
TakedaKAkiraSToll-like receptors in innate immunityInt Immunol2005171141:CAS:528:DC%2BD2cXhtVKru77P10.1093/intimm/dxh18615585605
HornerSMActivation and evasion of antiviral innate immunity by hepatitis C virusJ Mol Biol2014426119812091:CAS:528:DC%2BC3sXhslOjsL%2FO10.1016/j.jmb.2013.10.032
LiKFoyEFerreonJCImmune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the toll-like receptor 3 adaptor protein TRIF ProcNatl Acad Sci USA2005102299229971:CAS:528:DC%2BD2MXitVSkt7g%3D10.1073/pnas.0408824102
TakedaKAkiraSTLR signaling pathwaysSemin Immunol200416391:CAS:528:DC%2BD2cXntVOnsA%3D%3D10.1016/j.smim.2003.10.00314751757
ChenYChenJWangHHCV-induced miR-2 contributes to evasion of host immune system by targeting MyD88 and IRAK1PLoS Pathog20139e10032481:CAS:528:DC%2BC3sXntlCrurY%3D10.1371/journal.ppat.1003248
VersteegGAGarcia-SastreAViral tricks to grid-lock the type I interferon systemCurr Opin Microbiol2010135085161:CAS:528:DC%2BC3cXpvVaqtbw%3D10.1016/j.mib.2010.05.009
BaxtLAGarza-MayersACGoldbergMBBacterial subversion of host innate immune pathwaysScience20133406977011:CAS:528:DC%2BC3sXntVGjtro%3D10.1126/science.1235771
ChenKHuangJLiuYSynergy of TRIF-dependent TLR3 and MyD88-dependent TLR7 in up-regulating expression of mouse FPR2, a promiscuous G-protein- coupled receptor, in microglial cellsJ Neuroimmunol20092131-269771:CAS:528:DC%2BD1MXps1WhsLw%3D10.1016/j.jneuroim.2009.05.018195594902761824
PandeySKawaiTAkiraSMicrobial sensing by toll-like receptors and intracellular nucleic acid sensorsCold Spring Harb Perspect Biol20157a01624610.1101/cshperspect.a016246
MotavafMNoorbakhshFAlavianSMDistinct toll-like receptor 3 and 7 expression in peripheral blood mononuclear cells from patients with chronic hepatitis C infectionHepat Mon2014144e1642110.5812/hepatmon.16421247488963989766
HamdyOsmanZakariaAssociation of toll-like receptor 3 and toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among EgyptiansArch Virol20181639243324421:CAS:528:DC%2BC1cXhtVOls7nJ10.1007/s00705-018-3893-829860675
OrzalliMHKnipeDMCellular sensing of viral DNA and viral evasion mechanismsAnnu Rev Microbiol2014684774921:CAS:528:DC%2BC2cXhvVGrsbbO10.1146/annurev-micro-091313-103409
MetzPReuterABenderSInterferon-stimulated genes, and their role in controlling hepatitis C. virusJ Hepatol201359133113411:CAS:528:DC%2BC3sXhsFelurnL10.1016/j.jhep.2013.07.033
RayStuartCThomas“Chapter 154: Hepatitis C”. Principles and practice of infectious diseases20097PhiladelphiaChurchill LivingstoneISBN 978-0-443-06839-3
HiscottJNguyenTLArguelloMManipulation of the nuclear factor-kappa B pathway and the innate immune response by virusesOncogene.200625684468671:CAS:528:DC%2BD28XhtFekt7fF10.1038/sj.onc.1209941170723327100320
MohammedKIAdelLAAli-EldinFAExpression of toll like receptors 3 & 7 in peripheral blood from patients with chronic hepatitis C virus infection and their correlation with interferon-alphaEgypt J Immunol2013201132223888553
KamalSMAcute hepatitis C: a systematic reviewAm J Gastroenterol20081031283e129710.1111/j.1572-0241.2008.01825.x
UrbanowiczZagożdżonCiszekMModulation of the immune system in chronic hepatitis C and during antiviral interferon-free therapyArch Immunol Ther Exp201967279881:CAS:528:DC%2BC1cXit1Wiu7bF10.1007/s00005-018-0532-8Birkhauser Verlag AG
SantoroMGRossiAAmiciCNF-kB and virus infection: who controls whomEMBO J200322255225601:CAS:528:DC%2BD3sXkt1WrtL4%3D10.1093/emboj/cdg26712773372156764
HondaKTaniguchiTIRFs: master regulators of signaling by toll-like receptors and cytosolic pattern-recognition receptorsNat Rev Immunol200666446581:CAS:528:DC%2BD28Xos12gtrY%3D10.1038/nri1900
ElgharablyAGomaaAICrosseyMMHepatitis C in Egypt – past, present, and futureInt J Gen Med2017101610.2147/IJGM.S11930128053553
EasterbrookPJGroupWGDWho to test and how to test for chronic hepatitis C infection–2016 WHO testing guidance for low-and middle-income countriesJ Hepatol2016651S46S6610.1016/j.jhep.2016.08.002
GhonaimAzizMostafaToll-like receptor 7 expression and gene polymorphism in patients with hepatitis C and hepatocellular carcinomaEgypt J Med Microbiol2019284
HornungVRothenfusserSBritschSQuantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotidesJ Immunol2002168453145371:CAS:528:DC%2BD38Xjt12jt7k%3D10.4049/jimmunol.168.9.453111970999
AgrawalBKrishnadasDKKumarRProteins derived from hepatitis C virus modulate immune responses: targeting dendritic cellsInt Immunol20122227481:CAS:528:DC%2BC3cXms1OmsL8%3D10.1093/intimm/dxq033
SalemMIbrahimEMEl-BateHEx vivo generation and maturation of dendritic cells from peripheral blood mononuclear cells of patients with chronic HCV or hepatocellular carcinoma using toll-like receptor 3 ligand poly(I:C)Int J Cancer Biomed Res201821111810.21608/jcbr.2019.34740
References_xml – reference: PandeySKawaiTAkiraSMicrobial sensing by toll-like receptors and intracellular nucleic acid sensorsCold Spring Harb Perspect Biol20157a01624610.1101/cshperspect.a016246
– reference: MetzPReuterABenderSInterferon-stimulated genes, and their role in controlling hepatitis C. virusJ Hepatol201359133113411:CAS:528:DC%2BC3sXhsFelurnL10.1016/j.jhep.2013.07.033
– reference: LiKFoyEFerreonJCImmune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the toll-like receptor 3 adaptor protein TRIF ProcNatl Acad Sci USA2005102299229971:CAS:528:DC%2BD2MXitVSkt7g%3D10.1073/pnas.0408824102
– reference: GhonaimAzizMostafaToll-like receptor 7 expression and gene polymorphism in patients with hepatitis C and hepatocellular carcinomaEgypt J Med Microbiol2019284
– reference: JacobsBLLanglandJOWhen two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNAVirology.19962193393491:CAS:528:DyaK28XjtVSgt74%3D10.1006/viro.1996.02598638399
– reference: HiscottJNguyenTLArguelloMManipulation of the nuclear factor-kappa B pathway and the innate immune response by virusesOncogene.200625684468671:CAS:528:DC%2BD28XhtFekt7fF10.1038/sj.onc.1209941170723327100320
– reference: Dehghan-ManshadiMHadinedoushanHAmirbaigyMKRelative expression of toll-like receptors 2 and 7 mRNA in peripheral blood of patients with hepatitis CHepat Mon20151511e3042710.5812/hepatmon.30427268347884719121
– reference: HornungVRothenfusserSBritschSQuantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotidesJ Immunol2002168453145371:CAS:528:DC%2BD38Xjt12jt7k%3D10.4049/jimmunol.168.9.453111970999
– reference: ChenKHuangJLiuYSynergy of TRIF-dependent TLR3 and MyD88-dependent TLR7 in up-regulating expression of mouse FPR2, a promiscuous G-protein- coupled receptor, in microglial cellsJ Neuroimmunol20092131-269771:CAS:528:DC%2BD1MXps1WhsLw%3D10.1016/j.jneuroim.2009.05.018195594902761824
– reference: VersteegGAGarcia-SastreAViral tricks to grid-lock the type I interferon systemCurr Opin Microbiol2010135085161:CAS:528:DC%2BC3cXpvVaqtbw%3D10.1016/j.mib.2010.05.009
– reference: TakedaKAkiraSToll-like receptors in innate immunityInt Immunol2005171141:CAS:528:DC%2BD2cXhtVKru77P10.1093/intimm/dxh18615585605
– reference: UrbanowiczZagożdżonCiszekMModulation of the immune system in chronic hepatitis C and during antiviral interferon-free therapyArch Immunol Ther Exp201967279881:CAS:528:DC%2BC1cXit1Wiu7bF10.1007/s00005-018-0532-8Birkhauser Verlag AG
– reference: AgrawalBKrishnadasDKKumarRProteins derived from hepatitis C virus modulate immune responses: targeting dendritic cellsInt Immunol20122227481:CAS:528:DC%2BC3cXms1OmsL8%3D10.1093/intimm/dxq033
– reference: EasterbrookPJGroupWGDWho to test and how to test for chronic hepatitis C infection–2016 WHO testing guidance for low-and middle-income countriesJ Hepatol2016651S46S6610.1016/j.jhep.2016.08.002
– reference: MotavafMNoorbakhshFAlavianSMDistinct toll-like receptor 3 and 7 expression in peripheral blood mononuclear cells from patients with chronic hepatitis C infectionHepat Mon2014144e1642110.5812/hepatmon.16421247488963989766
– reference: MatsumotoMKikkawaSKohaseMEstablishment of a monoclonal antibody against human toll-like receptor 3 that blocks double-stranded RNA-mediated signalingBiochem Biophys Res Commun20022935136413691:CAS:528:DC%2BD38Xks1Ghu7c%3D10.1016/S0006-291X(02)00380-712054664
– reference: HondaKTaniguchiTIRFs: master regulators of signaling by toll-like receptors and cytosolic pattern-recognition receptorsNat Rev Immunol200666446581:CAS:528:DC%2BD28Xos12gtrY%3D10.1038/nri1900
– reference: ElgharablyAGomaaAICrosseyMMHepatitis C in Egypt – past, present, and futureInt J Gen Med2017101610.2147/IJGM.S11930128053553
– reference: LiangCaoDingHepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathwayPLoS Pathog2018145e10070751:CAS:528:DC%2BC1cXhvFCmtrjM10.1371/journal.ppat.1007075297825325983870
– reference: HamdyOsmanZakariaAssociation of toll-like receptor 3 and toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among EgyptiansArch Virol20181639243324421:CAS:528:DC%2BC1cXhtVOls7nJ10.1007/s00705-018-3893-829860675
– reference: SantoroMGRossiAAmiciCNF-kB and virus infection: who controls whomEMBO J200322255225601:CAS:528:DC%2BD3sXkt1WrtL4%3D10.1093/emboj/cdg26712773372156764
– reference: MohammedKIAdelLAAli-EldinFAExpression of toll like receptors 3 & 7 in peripheral blood from patients with chronic hepatitis C virus infection and their correlation with interferon-alphaEgypt J Immunol2013201132223888553
– reference: OrzalliMHKnipeDMCellular sensing of viral DNA and viral evasion mechanismsAnnu Rev Microbiol2014684774921:CAS:528:DC%2BC2cXhvVGrsbbO10.1146/annurev-micro-091313-103409
– reference: RayStuartCThomas“Chapter 154: Hepatitis C”. Principles and practice of infectious diseases20097PhiladelphiaChurchill LivingstoneISBN 978-0-443-06839-3
– reference: TakedaKAkiraSTLR signaling pathwaysSemin Immunol200416391:CAS:528:DC%2BD2cXntVOnsA%3D%3D10.1016/j.smim.2003.10.00314751757
– reference: BaxtLAGarza-MayersACGoldbergMBBacterial subversion of host innate immune pathwaysScience20133406977011:CAS:528:DC%2BC3sXntVGjtro%3D10.1126/science.1235771
– reference: RosadiniCVKaganJCMicrobial strategies for antagonizing toll-like-receptor signal transductionCurr Opin Immunol20153261701:CAS:528:DC%2BC2MXmtFWrsw%3D%3D10.1016/j.coi.2014.12.011
– reference: HornerSMActivation and evasion of antiviral innate immunity by hepatitis C virusJ Mol Biol2014426119812091:CAS:528:DC%2BC3sXhslOjsL%2FO10.1016/j.jmb.2013.10.032
– reference: SahaBSzaboGInnate immune cell networking in hepatitis C virus infectionJ Leukoc Biol201496.57577661:CAS:528:DC%2BC2cXitFWns7bJ10.1189/jlb.4MR0314-141R
– reference: KamalSMAcute hepatitis C: a systematic reviewAm J Gastroenterol20081031283e129710.1111/j.1572-0241.2008.01825.x
– reference: ChenYChenJWangHHCV-induced miR-2 contributes to evasion of host immune system by targeting MyD88 and IRAK1PLoS Pathog20139e10032481:CAS:528:DC%2BC3sXntlCrurY%3D10.1371/journal.ppat.1003248
– reference: SalemMIbrahimEMEl-BateHEx vivo generation and maturation of dendritic cells from peripheral blood mononuclear cells of patients with chronic HCV or hepatocellular carcinoma using toll-like receptor 3 ligand poly(I:C)Int J Cancer Biomed Res201821111810.21608/jcbr.2019.34740
SSID ssj0065374
Score 2.1646142
Snippet Background One possible mechanism utilized by hepatitis C virus (HCV) to escape from the host’s innate immune surveillance is modification of its...
Background One possible mechanism utilized by hepatitis C virus (HCV) to escape from the host's innate immune surveillance is modification of its...
One possible mechanism utilized by hepatitis C virus (HCV) to escape from the host's innate immune surveillance is modification of its pathogen-associated...
BackgroundOne possible mechanism utilized by hepatitis C virus (HCV) to escape from the host’s innate immune surveillance is modification of its...
Abstract Background One possible mechanism utilized by hepatitis C virus (HCV) to escape from the host’s innate immune surveillance is modification of its...
SourceID doaj
proquest
gale
springer
SourceType Open Website
Aggregation Database
Publisher
StartPage 13
SubjectTerms Analysis
B cells
Chemokines
Genotypes
Health aspects
Hepatitis C
Hepatitis C virus
IFN-α transcription
Immune response
Immunosurveillance
Inflammation
Innate immunity
Interferon
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Messenger RNA
mRNA
Pathogens
Peripheral blood
TLR3 and TLR7 signaling
TLR3 protein
TLR7 protein
Toll-like receptors
α-Interferon
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwELUqTr1UVBR1KUU-VOKCRRJ_xcctBSEOHFCRuFn22BFIkEUkK_ED-sM7k3hFEQcuvWYiy_HMOPOS8XuM_UhGZ9s5EFidV0KFDoSzlRMhI1iQkGRKU7fFpTm_Vhc3-uYfqS_qCZvpgeeFO65VnZOOykQdVLA2yjqoqLoM2rU5T8AH33kzmNqcimnN8aAIqAvqQKAyRwpVWPnf7r1vfoJO75azbfapFIV8OU_mM_uQ-x3251fRLsEcvOf5uXSs9nzVcerMveekJrzCABChrHFO_GEjd0tW-tjHcUvLj6Spwx-uLpf8ruenJD2GYcFhZsblt5n6qse7gZ_Q0OuBF7rV4Qu7Pjv9fXIuimaCAKxkRqEiuEq3ErBsUzrZJjU14H6MqCZDY1sTbQUpKXBtqyOoWMkgY3RKR6y9XJK7bKtf9fkr44hEMo7ldEg1mhHY1SFJk4MEBaarFuwnrad_nGkxPBFVTxfQfb64z7_nvgU7JG94SqfxKUAopwJwCkRM5ZfGOmKcMXLB9l_diWkAr80bf_qShoNvjKXDydq6BTva-PjFPAGg1vg5VjzGip9ixau9__Fs39jHZoq_BjNhn22NT-v8HUuYMR5M0foXXG_xng
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest_Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LaxRBEG40gngR4wNXY-iD4MUmM9Ov6ZOsMSEEzEEM7K3p12ggmdnsTMAf4A-3qrfHEAK5bi3NMPVVTVV39fcR8jEqmXRnAoPqvGLCdYEZXRnmEjQLPEQeY562OFMn5-J0JVdlw20sY5VzTsyJOg4B98gPGqXxnqnU5sv6mqFqFJ6uFgmNx-QJUpfhSJde_W-4lOSZhRnCuWKt4tV8aaZVB6PAPp7hgAJWQZyJQtp_PzXfOyPNn57jF-R5qRnpcuvkXfIo9S_J0-_lVPwV-futqJxAtF7S9KfMtvZ06CjO8F5S1B0eACrMFW-kSK9mYVy04rYgheSX1qi-Q69-nC3pRU-PUKQMAETDlkOX_k44gT1djPQQl74ZaSFmHV-T8-Ojn4cnrKgrsAA1z8SED6aSLQ9Q4AkZdRObOkDmhv4nhUa3yusqxCiCaVvpg_AVd9x7I6SHKs1E_obs9EOf3hIKPUuCtYx0sQYztIC1i1wlx4MIqqsW5Cu-WrveEmhYpLTOPwybX7ZECPQgdYrSC-WlE05rz2snvOhSkKZNqV6QT-gYi4E3bVxw5f4APAJSWNml0ga5aRRfkL07_4SACXfNs2ttCdjR3sJrQT7P7r4151apVXYLGwuwsRk2Vrx7eLX35FmTQdZANOyRnWlzkz5AGTP5_YzVf4b28Cw
  priority: 102
  providerName: ProQuest
Title Differential expression of viral pathogen-associated molecular pattern receptors mRNA in Egyptian chronic hepatitis C virus patients
URI https://link.springer.com/article/10.1186/s43042-021-00133-4
https://www.proquest.com/docview/2670521579
https://doaj.org/article/141ed5b46b5a4a77b31a4b4fec598ee1
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB6aBEovJX3RbdJFh0IvFbWtl3XcbDeEQpcSGtib0GtpIPGG2IH8gP7wzni1tCG99GoJYTTfyPNZM98AfEhaZbO2kWN0XnHp15FbU1nuM5IFEZNIacy2WOqzC_l1pVZFJodqYf6-v69b_bmXxLc5JRJQtCK43IMDVQtNCJ7r-a4O5p9Tiw7_49P20bXn-DU5PYTnJQxks63dXsCT3L2Ep9_KRfcr-PWlNC5BB7xi-b6kq3Zss2aUlnvFqJXwBq3PfdngnNj1rtctjdKfPobnWb6hhjrs-nw5Y5cdW1DfMcQEi1tZXPYzU1L1cNmzOS1917Oitdq_hovTxY_5GS8NE3jEMGbgMkRbqVZEjNmkSqZJTR3xMEZKk2NjWh1MFVOS0batClGGSngRgpUqYOBlk3gD-92my2-BIQ3JuJZVPtU4jKyu9kno7EWUUa-rCZzQ1rqbrSaGI5Xq8QEazxXQI62oc1JB6qC89MYEUXsZ5DpHZduc6wl8JMM48qXh1kdfSgLwFUiVys20sSQ3o8UEjh_MRB-ID4d3pnXFB3vXaEOVycrYCXzamfvP8Mh-Wu22sHEIGzfCxsl3_zf9CJ41I-gaBPwx7A-3d_k9RipDmMKeWZkpHJwslt_PpyNgpyPr_w1sb-e-
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV1Lb9QwELZKKwEX3oiFAj6AuOA2iR-JDxyW3ZYtbfeAWtGb61do1TZbbbLiceZf8Ff4cYwTR1WpxK0S1_VqFDnffJ5xvplB6JUT3OeltASi84QwXVoi80QS7SFZoNZR51q1xVRM9tnHA36whH71tTBBVtlzYkvUbmbDHfl6JvJQZ8pzGRWU2_77V8jP6ndbY3iZr7Nsc2NvNCFxhACxcLA3hBkrE15QC1EM4y7PXJZaoCcI8r3N8kKYPLHOMSuLghvLTEI1NUYybiAUkY6C3RtoBbIKDu6zMvo8_jDpiV5w2jZ5BrZISCFo0tfkFGK9ZuGagAT9QwiyKGFxJsBV5r_yCbY92Tbvot_9nnSClpO1RWPW7I-_2kX-p5t2D92JETUedi5wHy356gG6uRs1Aw_Rz3GcAQNcdor9t6j8rfCsxEHhfIrDVOYZOBLREave4bN-bHBYDZemGI4Gfx5mE-GzT9MhPq7wRhjhBu6FbddhGB_5oE9vjms8CqYXNY5ta-tHaP9a9uAxWq5mlX-CMGR0HmxJrl0Ky5Agp9pR4TW1zIoyGaD3ARnqvGsvokLD7_aH2fyLivwBGVrqHTdMGK6ZznNDU80MK73lsvA-HaA3AVcq0FIz11bH6gp4hNDgSw1FLkPnHkEHaPXSP4FO7OXlHkoq0lmtLnA0QG97tF4st4lkIVSHegWoVy3qFXv6b2sv0a3J3u6O2tmabj9Dt7PWXzLgjVW03MwX_jkEfI15ER0Po8Prhu0f9i9hbA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELbKVqq48EYsFPABxAV3k_iR-IDQstulpbBCiIreXL8CFe3ussmKx5lfxV_hzzBOHFWlErceuMaRFTnffDNjj-dD6JET3OeltASi84QwXVoi80QS7SFZoNZR55pqi6nY2WevDvjBGvrV3YUJZZUdJzZE7eY27JEPMpGHe6Y8l4MylkW8HU-eL76QoCAVTlo7OY0WInv--1dI36pnu2P414-zbLL9frRDosIAseD3a8KMlQkvqIUgh3GXZy5LLbAX5ADeZnkhTJ5Y55iVRcGNZSahmhojGTcQqUhHYd5LaD2oOrEeWh99GL_c6fyA4LTpAQ1kkpBC0KS7slOIQcXCLgIJ5REhBqOERcmA847h3Alt4_gmV9HvbsnaepfPW6vabNkff3WT_D_X9Bq6EuNxPGwN6Dpa87MbaONNrDi4iX6Oo4IMMOEx9t9i3fAMz0sc6qOPcdB0noMZEh2R7h0-6USHw2jYcsXgWPwiKBvhk3fTIT6a4e0gAAfGiW3bnxh_8qG6vT6q8ChMvapwbHpb3UL7F7IGt1FvNp_5OwhDPuhhLsm1S2EY0utUOyq8ppZZUSZ99CIARy3a5iQqtAtvHsyXH1VkH8jvUu-4YcJwzXSeG5pqZljpLZeF92kfPQmwU4HU6qW2Ot7NgE8I7cHUUOQy9P0RtI82z7wJZGTPDndIU5EMK3UKsz562oH5dLhJQwuhWqNQYBSqMQrF7v57todoA-CqXu9O9-6hy1ljTRmQzibq1cuVvw_RYm0eRLPE6PCiUfsHDx95PA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+expression+of+viral+pathogen-associated+molecular+pattern+receptors+mRNA+in+Egyptian+chronic+hepatitis+C+virus+patients&rft.jtitle=Egyptian+Journal+of+Medical+Human+Genetics&rft.au=Suef%2C+Reda+A.&rft.au=Mohamed%2C+Ezz+Elden+M.&rft.au=Mansour%2C+Mohamed+T.+M.&rft.au=Weigand%2C+Kilian&rft.date=2021-02-26&rft.pub=Springer+Berlin+Heidelberg&rft.eissn=2090-2441&rft.volume=22&rft.issue=1&rft_id=info:doi/10.1186%2Fs43042-021-00133-4&rft.externalDocID=10_1186_s43042_021_00133_4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1110-8630&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1110-8630&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1110-8630&client=summon